ClariVest Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-96,505
| Closed | -$2.28M | – | 925 |
|
|
2023
Q4 | $2.28M | Buy |
96,505
+24
| +0% | +$567 | 0.13% | 121 |
|
|
2023
Q3 | $1.44M | Sell |
96,481
-63,600
| -40% | -$948K | 0.08% | 166 |
|
|
2023
Q2 | $1.75M | Buy |
160,081
+28,940
| +22% | +$317K | 0.09% | 148 |
|
|
2023
Q1 | $1.14M | Sell |
131,141
-159
| -0.1% | -$1.39K | 0.05% | 266 |
|
|
2022
Q4 | $824K | Sell |
131,300
-1,700
| -1% | -$10.7K | 0.04% | 304 |
|
|
2022
Q3 | $465K | Hold |
133,000
| – | – | 0.02% | 371 |
|
|
2022
Q2 | $392K | Hold |
133,000
| – | – | 0.02% | 409 |
|
|
2022
Q1 | $413K | Sell |
133,000
-19,500
| -13% | -$60.6K | 0.02% | 412 |
|
|
2021
Q4 | $515K | Buy |
152,500
+39,000
| +34% | +$132K | 0.02% | 431 |
|
|
2021
Q3 | $415K | Sell |
113,500
-700
| -0.6% | -$2.56K | 0.01% | 454 |
|
|
2021
Q2 | $498K | Hold |
114,200
| – | – | 0.02% | 432 |
|
|
2021
Q1 | $518K | Buy |
114,200
+24,700
| +28% | +$112K | 0.02% | 408 |
|
|
2020
Q4 | $514K | Sell |
89,500
-16,300
| -15% | -$93.6K | 0.02% | 374 |
|
|
2020
Q3 | $766K | Sell |
105,800
-6,600
| -6% | -$47.8K | 0.03% | 322 |
|
|
2020
Q2 | $392K | Buy |
+112,400
| New | +$392K | 0.01% | 443 |
|
|
2017
Q2 | – | Sell |
-24,341
| Closed | -$105K | – | 738 |
|
|
2017
Q1 | $105K | Buy |
+24,341
| New | +$105K | ﹤0.01% | 553 |
|